Research Progress on Local Treatment of Malignant Pleural Effusion.
10.3779/j.issn.1009-3419.2025.102.32
- Author:
Yanjun DU
1
;
Ping ZHAN
1
;
Tangfeng LV
1
;
Yong SONG
1
Author Information
1. Department of Respiratory and Critical Care Medicine, Jinling Clinical Medical College, Nanjing Medical University, Nanjing 210002, China.
- Publication Type:English Abstract
- Keywords:
Immune microenvironment;
Local therapies;
Malignant pleural effusion;
Progress
- MeSH:
Humans;
Pleural Effusion, Malignant/drug therapy*
- From:
Chinese Journal of Lung Cancer
2025;28(8):629-637
- CountryChina
- Language:Chinese
-
Abstract:
Malignant pleural effusion (MPE) refers to the accumulation of pleural fluid caused by metastasis from primary pleural malignancies or tumors originating elsewhere. It is associated with a poor prognosis. Current treatment strategies primarily include systemic anti-tumor therapy and local management of MPE based on the primary tumor. Numerous studies have documented diverse approaches for the local control of MPE. This review summarizes recent advances in local treatment strategies for primary tumor-related MPE, highlighting emerging pharmacological agents and innovative techniques.
.
